Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeladon Pharmaceuticals Regulatory News (CEL)

  • This share is currently suspended. It was suspended at a price of 13.40
  • There is currently no data for CEL

Annual Report Notification

3 Jul 2008 14:39

RNS Number : 2749Y
Celsis International PLC
03 July 2008
 



FOR release: Thursday 3 July 2008

CELSIS INTERNATIONAL PLC

("Celsis", "the Company" or "the Group")

Annual Report & Accounts

3 July 2008: Celsis International plc, the international life sciences products and laboratory services company, today announces that copies of the Company's Annual Report and Accounts 2008 have been submitted to the UK Listing Authority (UKLA) and will shortly be delivered for inspection at the UKLA Document Viewing Facility, which is situated at:

 

Financial Services Authority 

25 The North Colonnade 

London 

E14 5HS 

020 7066 1000

For further information please contact:

Celsis International plc
Tel: +44 (0) 1223 598 428
Christian Madrolle, Finance Director & Company Secretary
 
Jenny Woolway, Corporate Communications
 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBXGDRUXGGGIX
Date   Source Headline
4th Aug 20058:00 amRNSDirector/PDMR Shareholding
26th Jul 20055:07 pmRNSResult of AGM
26th Jul 20057:00 amRNSAGM Statement
18th Jul 20054:35 pmRNSDividend Declaration
11th Jul 20054:58 pmRNSHolding(s) in Company
30th Jun 200511:42 amRNSAnnual Report and Accounts
28th Jun 20057:01 amRNSRe: Share Capital
10th Jun 20053:38 pmRNSTreasury Stock
6th Jun 20054:59 pmRNSDirector Shareholding
2nd Jun 200511:03 amRNSHolding(s) in Company
31st May 20059:07 amRNSDirector Shareholding
24th May 20057:01 amRNSFinal Results
16th May 20054:08 pmRNSNotice of Results
1st Apr 20057:00 amRNSTrading Statement
1st Mar 20057:01 amRNSBoard Change
18th Feb 20054:33 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.